TIL Therapy Research Expanded to Bladder Cancer

Almost half of patients enrolled in a Moffitt trial responded to the cellular immunotherapy

Can Hybrid Immunotherapy Improve Solid Tumor Treatment?

Moffitt researchers test CAR-TIL cells combining tumor navigation and targeted attack

Study Looks To Improve TIL Therapy for Advanced Melanoma

TIL therapy can be used to treat advanced melanoma when patients do not respond to standard treatment options

Moffitt Launches Immunotherapy Podcast

Monthly series highlights visionaries in immunotherapy and the breakthroughs that are transforming lives

Moffitt Study Shows New Immune Boost Could Expand Access to Cancer Immunotherapy

Adding a natural protein improves the speed and success of TIL manufacturing, potentially benefiting more patients

Can Low-Oxygen Conditions Improve TIL Therapy for Kidney Cancer?

Growing TILs in an environment with 5% oxygen improved efficacy of treatment, study says

Endeavor